Surgery Partners Inc (SGRY)

Currency in USD
16.77
+0.27(+1.64%)
Closed·
16.770.00(0.00%)
·
SGRY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.4116.93
52 wk Range
11.4124.10
Key Statistics
Prev. Close
16.5
Open
16.53
Day's Range
16.41-16.93
52 wk Range
11.41-24.1
Volume
1.3M
Average Volume (3m)
1.4M
1-Year Change
-24.7138%
Book Value / Share
13.17
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SGRY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
17.95
Upside
+7.06%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Surgery Partners Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy

Analyst Ratings

9 Buy
3 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 17.95
(+7.06% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Cantor Fitzgerald
Buy18.00+7.33%-MaintainJul 02, 2026
Cantor Fitzgerald
Buy18.00+7.33%-MaintainJul 01, 2026
TD Cowen
Buy17.00+1.37%20.00MaintainMay 08, 2026
Jefferies
Buy15.00-10.55%16.25MaintainApr 20, 2026
Cantor Fitzgerald
Buy25.00+49.08%-MaintainApr 15, 2026

Surgery Partners Inc SWOT Analysis


Strategic Resilience
Surgery Partners reaffirms 2025 guidance after ending take-private talks, showcasing confidence in its business strategy amid healthcare sector challenges
Financial Landscape
Analysts project EPS growth from $0.61 to $0.80, with price targets ranging from $24 to $35, reflecting mixed views on the company's profitability potential
Operational Excellence
Delve into Surgery Partners' physician recruitment success and efficiency improvements, key drivers for expanding service offerings and mitigating rising costs
Market Dynamics
Explore how Surgery Partners navigates stable surgical demand and pricing pressures, positioning itself in the evolving outpatient care landscape
Read full SWOT analysis

Surgery Partners Inc Earnings Call Summary for Q1/2026

  • Q1 2026 EPS of -$0.03 beat forecast of -$0.12 by 75%; revenue reached $810.9M, exceeding expectations by 1.7%
  • Adjusted EBITDA hit $102M; operating cash flow doubled to $12M from $6M in Q1 2025; stock rose 2.68% pre-market to $14.58
  • Strategic focus on surgical robotics expansion and total joints procedures driving growth amid industry shift to ambulatory centers
  • Analysts forecast profitability in 2026 with $0.10 EPS; consensus Buy rating with $25 price target suggests 79% upside potential
  • Key risks include payer mix pressures, Medicaid rate cuts, weather disruptions, and rising interest expenses impacting margins
Last Updated: 2026-05-05, 10:00 a/m
Read Full Transcript

Earnings

Latest Release
May 05, 2026
EPS / Forecast
-0.03 / -0.12
Revenue / Forecast
810.9M / 797.32M
EPS Revisions
Last 90 days

SGRY Income Statement

Compare SGRY to Peers and Sector

Metrics to compare
SGRY
Peers
Sector
Relationship
P/E Ratio
−28.6x−5.1x−0.4x
PEG Ratio
−0.460.110.00
Price/Book
1.3x10.5x2.6x
Price / LTM Sales
0.6x0.3x3.0x
Upside (Analyst Target)
6.1%−42.4%51.9%
Fair Value Upside
Unlock30.7%9.1%Unlock

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
42.45M32.76%700.46M
Other Institutional Investors
117.15M67.24%1.93B
Public Companies & Retail Investors
0.000.00%0.00
Total
159.6M100.00%2.63B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Bain Capital, LP38.55%49,946,972824,125
Janus Henderson Group Ltd.10.45%13,540,385223,416

People Also Watch

93.65
XMTR
+4.62%
70.29
MRX
+4.63%
9.390
GBTG
-0.11%
83.48
STRA
+0.85%

FAQ

What Is the Surgery Partners Inc (SGRY) Stock Price Today?

The Surgery Partners Inc stock price today is 16.77 USD.

What Stock Exchange Does Surgery Partners Inc Trade On?

Surgery Partners Inc is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Surgery Partners Inc?

The stock symbol for Surgery Partners Inc is "SGRY."

What Is the Surgery Partners Inc Market Cap?

As of today, Surgery Partners Inc market cap is 2.16B USD.

What Is Surgery Partners Inc's Earnings Per Share (TTM)?

The Surgery Partners Inc EPS (TTM) is -0.60.

When Is the Next Surgery Partners Inc Earnings Date?

Surgery Partners Inc will release its next earnings report on Aug 04, 2026.

From a Technical Analysis Perspective, Is SGRY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Surgery Partners Inc Stock Split?

Surgery Partners Inc has split 0 times.

How Many Employees Does Surgery Partners Inc Have?

Surgery Partners Inc has 16000 employees.

What is the current trading status of Surgery Partners Inc (SGRY)?

As of Jul 10, 2026, Surgery Partners Inc (SGRY) is trading at a price of 16.77 USD, with a previous close of 16.50 USD. The stock has fluctuated within a day range of 16.41 USD to 16.93 USD, while its 52-week range spans from 11.41 USD to 24.10 USD.

What Is Surgery Partners Inc (SGRY) Price Target According to Analysts?

The average 12-month price target for Surgery Partners Inc is 17.95 USD, with a high estimate of 24 USD and a low estimate of 14 USD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +7.06% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.